Reshape Lifesciences Inc
(FRA:24O0)
€
4.93
0 (0%)
Market Cap: 3.47 Mil
Enterprise Value: 2.38 Mil
PE Ratio: 0
PB Ratio: 0.97
GF Score: 35/100 Reshape Lifesciences Inc (FRA:24O0) Transcripts
- Q1 2024 ReShape Lifesciences Inc Earnings Call TranscriptMay 15, 2024Earnings
- Q4 2023 ReShape Lifesciences Inc Earnings Call TranscriptApr 01, 2024Earnings
- Q3 2023 ReShape Lifesciences Inc Earnings Call TranscriptNov 08, 2023€4.93Earnings
- Q2 2023 ReShape Lifesciences Inc Earnings Call TranscriptAug 07, 2023€4.93Earnings
- ReShape Lifesciences Inc at OTC Markets Life Science Investor Forum TranscriptJun 22, 2023
- Q1 2023 ReShape Lifesciences Inc Earnings Call TranscriptMay 15, 2023€4.93Earnings
- Q4 2022 ReShape Lifesciences Inc Earnings Call TranscriptApr 25, 2023€4.93Earnings
- Q3 2022 ReShape Lifesciences Inc Earnings Call TranscriptNov 14, 2022€10.87 (-1.54%)Earnings
- Q2 2022 ReShape Lifesciences Inc Earnings Call TranscriptAug 15, 2022€22.36 (-3.14%)Earnings
- Q1 2022 ReShape Lifesciences Inc Earnings Call TranscriptMay 23, 2022€38 (-1.59%)Earnings
- Q4 2021 ReShape Lifesciences Inc Earnings Call TranscriptMar 28, 2022€63.25 (+4.12%)Earnings
- ReShape Lifesciences Inc at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (Virtual) TranscriptSep 20, 2021
- Q4 2019 Obalon Therapeutics Inc Earnings Call TranscriptFeb 27, 2020Earnings
- Q3 2019 Obalon Therapeutics Inc Earnings Call TranscriptNov 08, 2019Earnings
- Q2 2019 Obalon Therapeutics Inc Earnings Call TranscriptJul 24, 2019Earnings
- Q4 2018 Obalon Therapeutics Inc Earnings Call TranscriptFeb 22, 2019Earnings
- 1